Medicare 2005: Big cuts on drugs, modest CF increase

Why This Topic Matters

The article helps readers understand how Medicare payment proposals can affect practice revenue, especially when drug reimbursement changes and physician fee schedule updates move in opposite directions. It also highlights coding-related developments that may influence documentation and diagnosis specificity in ObGyn care.

Article Sections

1. Medicare 2005 physician fee schedule proposal

   Introduces the proposed Medicare payment update released by CMS and frames the expected impact on ObGyn reimbursement. The section sets up the broader policy and revenue context for the article.

2. Drug reimbursement changes

   Summarizes the article’s discussion of changes affecting oncology-related drug payments and the reasons CMS gives for those changes. It also places the drug payment shifts in the context of ObGyn practice revenue.

3. New ICD-9 codes and ObGyn documentation

   Notes the release of new diagnosis codes and their relevance to specificity and medical necessity in women’s health coding. The section focuses on the coding update context rather than individual code details.

4. Conversion factor update and overall reimbursement impact

   Explains the proposed conversion factor change and the article’s summary of its expected effect on overall Medicare reimbursement. It also discusses how payment components interact within ObGyn practice revenue.

5. Outlook for the final fee schedule

   Provides brief commentary on the policy process leading up to the final fee schedule. The section indicates that additional changes and stakeholder responses were expected later in the year.